000 01219 a2200289 4500
005 20250516183448.0
264 0 _c20140825
008 201408s 0 0 eng d
022 _a1532-8511
024 7 _a10.1016/j.jstrokecerebrovasdis.2013.09.023
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNedelman, Cassandra B
245 0 0 _aEffect of tissue plasminogen activator dose and interval on stroke severity.
_h[electronic resource]
260 _bJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
_cJan 2014
300 _a197-8 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aBrain Ischemia
_xcomplications
650 0 4 _aFemale
650 0 4 _aFibrinolytic Agents
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aStroke
_xcomplications
650 0 4 _aTissue Plasminogen Activator
_xadministration & dosage
700 1 _aGlenn, Loyd L
773 0 _tJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
_gvol. 23
_gno. 1
_gp. 197-8
856 4 0 _uhttps://doi.org/10.1016/j.jstrokecerebrovasdis.2013.09.023
_zAvailable from publisher's website
999 _c23322266
_d23322266